Indication
Pneumococcal pneumonia
Pneumococcal pneumonia is an acute lower respiratory tract infection caused by the bacterium *Streptococcus pneumoniae*, representing one of the leading causes of bacterial community-acquired pneumonia. Read more about Pneumococcal pneumonia
420 drugs 160 manufacturers
Drugs that treat it
Common Pneumococcal pneumonia therapies.
CLINDAMYCIN PHOSPHATE-D5W (clindamycin phosphate/dextrose 5 % in water)
CLINDAMYCIN HCL
CLINDAMYCIN PEDIATRIC (clindamycin palmitate HCl)
AZITHROMYCIN
LEVOFLOXACIN
MOXIFLOXACIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPneumococcal pneumonia is an acute lower respiratory tract infection caused by the bacterium *Streptococcus pneumoniae*, representing one of the leading causes of bacterial community-acquired pneumonia.
It affects the pulmonary parenchymal tissue—frequently producing lobar consolidation—and disproportionately impacts adults aged 65 and older, children younger than 5, and individuals with chronic cardiopulmonary diseases or immunocompromising conditions.
The clinical state is characterized by alveolar inflammation, purulent exudation, and impaired gas exchange, manifesting with an abrupt onset of fever, rigors, dyspnea, pleuritic chest pain, and a productive cough that often yields classic rust-colored sputum.
- nih.gov
Pneumococcal pneumonia is an acute lower respiratory tract infection caused by the bacterium *Streptococcus pneumoniae*, representing one of the leading causes of bacterial community-acquired pneumonia It affects the pulmonary parenchymal tissue—frequently producing lobar consolidation—and disproportionately impacts adults aged 65 and older, children younger than 5, and individuals with chronic cardiopulmonary diseases or immunocompromising conditions
- cdc.gov
It affects the pulmonary parenchymal tissue—frequently producing lobar consolidation—and disproportionately impacts adults aged 65 and older, children younger than 5, and individuals with chronic cardiopulmonary diseases or immunocompromising conditions
- cdc.gov
The clinical state is characterized by alveolar inflammation, purulent exudation, and impaired gas exchange, manifesting with an abrupt onset of fever, rigors, dyspnea, pleuritic chest pain, and a productive cough that often yields classic rust-colored sputum
Personalize your experience
Follow Pneumococcal pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.